25 XP   0   0   10

Guangzhou Kingmed Diagnostics Group Co Ltd
Buy, Hold or Sell?

Let's analyse Kingmed together

PenkeI guess you are interested in Guangzhou Kingmed Diagnostics Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangzhou Kingmed Diagnostics Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guangzhou Kingmed Diagnostics Group Co Ltd

I send you an email if I find something interesting about Guangzhou Kingmed Diagnostics Group Co Ltd.

Quick analysis of Kingmed (30 sec.)










What can you expect buying and holding a share of Kingmed? (30 sec.)

How much money do you get?

How much money do you get?
¥0.25
When do you have the money?
1 year
How often do you get paid?
96.4%

What is your share worth?

Current worth
¥18.51
Expected worth in 1 year
¥18.75
How sure are you?
92.9%

+ What do you gain per year?

Total Gains per Share
¥2.03
Return On Investment
5.3%

For what price can you sell your share?

Current Price per Share
¥38.35
Expected price per share
¥0 - ¥56.06
How sure are you?
50%

1. Valuation of Kingmed (5 min.)




Live pricePrice per Share (EOD)

¥38.35

Intrinsic Value Per Share

¥-51.82 - ¥-63.25

Total Value Per Share

¥-33.31 - ¥-44.74

2. Growth of Kingmed (5 min.)




Is Kingmed growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$1b$140.9m11.7%

How much money is Kingmed making?

Current yearPrevious yearGrowGrow %
Making money$30.3m$103.4m-$73m-240.2%
Net Profit Margin9.3%19.2%--

How much money comes from the company's main activities?

3. Financial Health of Kingmed (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#27 / 144

Most Revenue
#12 / 144

Most Profit
#7 / 144

What can you expect buying and holding a share of Kingmed? (5 min.)

Welcome investor! Kingmed's management wants to use your money to grow the business. In return you get a share of Kingmed.

What can you expect buying and holding a share of Kingmed?

First you should know what it really means to hold a share of Kingmed. And how you can make/lose money.

Speculation

The Price per Share of Kingmed is ¥38.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kingmed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kingmed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥18.51. Based on the TTM, the Book Value Change Per Share is ¥0.06 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.51 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.45 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kingmed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.090.2%0.060.2%0.220.6%0.110.3%0.080.2%
Usd Book Value Change Per Share0.090.2%0.010.0%0.210.5%0.100.3%0.090.2%
Usd Dividend Per Share0.000.0%0.060.2%0.050.1%0.030.1%0.020.1%
Usd Total Gains Per Share0.090.2%0.070.2%0.250.7%0.130.3%0.110.3%
Usd Price Per Share8.61-10.50-11.42-11.01-8.61-
Price to Earnings Ratio25.10-47.41-13.85-40.71-50.22-
Price-to-Total Gains Ratio96.32-170.12-45.25-244.75--31.24-
Price to Book Ratio3.37-4.08-5.19-8.60-7.58-
Price-to-Total Gains Ratio96.32-170.12-45.25-244.75--31.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.296135
Number of shares188
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.03
Usd Book Value Change Per Share0.010.10
Usd Total Gains Per Share0.070.13
Gains per Quarter (188 shares)13.1923.82
Gains per Year (188 shares)52.7695.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
147643207585
293129640151180
31401914960226275
41862520280302370
52333125599377465
627937308119452560
732644361139528655
837250414159603750
941956467179679845
1046562520199754940

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%28.00.00.0100.0%28.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%18.01.01.090.0%24.02.02.085.7%24.02.02.085.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.01.095.0%27.00.01.096.4%27.00.01.096.4%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.00.01.095.0%26.01.01.092.9%26.01.01.092.9%

Fundamentals of Kingmed

About Guangzhou Kingmed Diagnostics Group Co Ltd

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. The company also offers clinical research, health management, cold chain logistics, and scientific research services, as well as vitro diagnostics, big data, artificial intelligence, and forensic testing services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.

Fundamental data was last updated by Penke on 2024-04-18 14:33:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Guangzhou Kingmed Diagnostics Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Kingmed earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Kingmed to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 14.6% means that ¥0.15 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The MRQ is 14.6%. The company is making a huge profit. +2
  • The TTM is 9.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ14.6%TTM9.3%+5.3%
TTM9.3%YOY19.2%-9.9%
TTM9.3%5Y13.4%-4.1%
5Y13.4%10Y11.0%+2.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ14.6%-7.3%+21.9%
TTM9.3%-6.7%+16.0%
YOY19.2%-1.9%+21.1%
5Y13.4%-1.5%+14.9%
10Y11.0%-3.4%+14.4%
1.1.2. Return on Assets

Shows how efficient Kingmed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kingmed to the Diagnostics & Research industry mean.
  • 2.4% Return on Assets means that Kingmed generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The MRQ is 2.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.4%TTM1.7%+0.7%
TTM1.7%YOY5.9%-4.2%
TTM1.7%5Y4.2%-2.5%
5Y4.2%10Y3.4%+0.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4%-1.6%+4.0%
TTM1.7%-1.3%+3.0%
YOY5.9%-0.9%+6.8%
5Y4.2%-0.5%+4.7%
10Y3.4%-0.9%+4.3%
1.1.3. Return on Equity

Shows how efficient Kingmed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kingmed to the Diagnostics & Research industry mean.
  • 3.4% Return on Equity means Kingmed generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The MRQ is 3.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.4%TTM2.6%+0.9%
TTM2.6%YOY10.0%-7.4%
TTM2.6%5Y7.5%-4.9%
5Y7.5%10Y6.3%+1.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4%-0.5%+3.9%
TTM2.6%0.2%+2.4%
YOY10.0%-0.3%+10.3%
5Y7.5%-1.4%+8.9%
10Y6.3%-2.3%+8.6%

1.2. Operating Efficiency of Guangzhou Kingmed Diagnostics Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Kingmed is operating .

  • Measures how much profit Kingmed makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kingmed to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM10.6%-10.6%
TTM10.6%YOY23.5%-12.9%
TTM10.6%5Y16.3%-5.6%
5Y16.3%10Y11.6%+4.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--8.8%+8.8%
TTM10.6%0.5%+10.1%
YOY23.5%4.0%+19.5%
5Y16.3%3.7%+12.6%
10Y11.6%-1.3%+12.9%
1.2.2. Operating Ratio

Measures how efficient Kingmed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.60 means that the operating costs are ¥1.60 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The MRQ is 1.599. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.505. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.599TTM1.505+0.093
TTM1.505YOY1.289+0.216
TTM1.5055Y1.321+0.184
5Y1.32110Y1.103+0.218
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5991.280+0.319
TTM1.5051.304+0.201
YOY1.2891.240+0.049
5Y1.3211.242+0.079
10Y1.1031.205-0.102

1.3. Liquidity of Guangzhou Kingmed Diagnostics Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Kingmed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.92 means the company has ¥2.92 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The MRQ is 2.919. The company is able to pay all its short-term debts. +1
  • The TTM is 2.601. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.919TTM2.601+0.319
TTM2.601YOY2.134+0.467
TTM2.6015Y1.973+0.628
5Y1.97310Y1.409+0.564
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9192.111+0.808
TTM2.6012.298+0.303
YOY2.1342.599-0.465
5Y1.9733.012-1.039
10Y1.4093.081-1.672
1.3.2. Quick Ratio

Measures if Kingmed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kingmed to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.05 means the company can pay off ¥2.05 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The MRQ is 2.049. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.815. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.049TTM1.815+0.235
TTM1.815YOY1.441+0.374
TTM1.8155Y1.299+0.516
5Y1.29910Y1.190+0.109
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0491.230+0.819
TTM1.8151.345+0.470
YOY1.4411.661-0.220
5Y1.2991.957-0.658
10Y1.1902.295-1.105

1.4. Solvency of Guangzhou Kingmed Diagnostics Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Kingmed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kingmed to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.29 means that Kingmed assets are financed with 28.7% credit (debt) and the remaining percentage (100% - 28.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The MRQ is 0.287. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.323. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.287TTM0.323-0.036
TTM0.323YOY0.395-0.072
TTM0.3235Y0.424-0.101
5Y0.42410Y0.453-0.030
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2870.432-0.145
TTM0.3230.407-0.084
YOY0.3950.394+0.001
5Y0.4240.448-0.024
10Y0.4530.446+0.007
1.4.2. Debt to Equity Ratio

Measures if Kingmed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kingmed to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 41.1% means that company has ¥0.41 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The MRQ is 0.411. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.492. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.411TTM0.492-0.080
TTM0.492YOY0.674-0.183
TTM0.4925Y0.777-0.285
5Y0.77710Y0.884-0.108
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4110.606-0.195
TTM0.4920.571-0.079
YOY0.6740.603+0.071
5Y0.7770.651+0.126
10Y0.8840.739+0.145

2. Market Valuation of Guangzhou Kingmed Diagnostics Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Kingmed generates.

  • Above 15 is considered overpriced but always compare Kingmed to the Diagnostics & Research industry mean.
  • A PE ratio of 25.10 means the investor is paying ¥25.10 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The EOD is 15.435. Based on the earnings, the company is fair priced.
  • The MRQ is 25.099. Based on the earnings, the company is overpriced. -1
  • The TTM is 47.410. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD15.435MRQ25.099-9.664
MRQ25.099TTM47.410-22.311
TTM47.410YOY13.848+33.562
TTM47.4105Y40.714+6.696
5Y40.71410Y50.221-9.507
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD15.435-0.259+15.694
MRQ25.099-0.395+25.494
TTM47.410-0.199+47.609
YOY13.848-0.008+13.856
5Y40.7143.483+37.231
10Y50.2214.434+45.787
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The EOD is -39.121. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -63.614. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -76.529. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-39.121MRQ-63.614+24.493
MRQ-63.614TTM-76.529+12.914
TTM-76.529YOY-0.982-75.547
TTM-76.5295Y-54.806-21.722
5Y-54.80610Y-37.519-17.288
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-39.121-0.405-38.716
MRQ-63.614-0.561-63.053
TTM-76.529-1.388-75.141
YOY-0.982-2.175+1.193
5Y-54.806-1.249-53.557
10Y-37.519-1.895-35.624
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Kingmed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.37 means the investor is paying ¥3.37 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guangzhou Kingmed Diagnostics Group Co Ltd:

  • The EOD is 2.072. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.369. Based on the equity, the company is fair priced.
  • The TTM is 4.076. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.072MRQ3.369-1.297
MRQ3.369TTM4.076-0.707
TTM4.076YOY5.185-1.109
TTM4.0765Y8.600-4.524
5Y8.60010Y7.576+1.024
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.0722.018+0.054
MRQ3.3692.211+1.158
TTM4.0762.168+1.908
YOY5.1853.014+2.171
5Y8.6003.475+5.125
10Y7.5764.079+3.497
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guangzhou Kingmed Diagnostics Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6450.060+976%1.515-57%0.726-11%0.661-2%
Book Value Per Share--18.51018.638-1%16.461+12%11.096+67%8.864+109%
Current Ratio--2.9192.601+12%2.134+37%1.973+48%1.409+107%
Debt To Asset Ratio--0.2870.323-11%0.395-27%0.424-32%0.453-37%
Debt To Equity Ratio--0.4110.492-16%0.674-39%0.777-47%0.884-53%
Dividend Per Share--0.0030.448-99%0.329-99%0.192-99%0.154-98%
Eps--0.6210.470+32%1.598-61%0.803-23%0.604+3%
Free Cash Flow Per Share---0.2450.182-234%0.780-131%0.411-160%0.272-190%
Free Cash Flow To Equity Per Share---0.245-0.420+71%0.402-161%0.175-240%0.176-239%
Gross Profit Margin--1.0001.0000%1.0000%0.950+5%0.964+4%
Intrinsic Value_10Y_max---63.245--------
Intrinsic Value_10Y_min---51.816--------
Intrinsic Value_1Y_max--0.660--------
Intrinsic Value_1Y_min--0.652--------
Intrinsic Value_3Y_max---3.350--------
Intrinsic Value_3Y_min---3.090--------
Intrinsic Value_5Y_max---13.789--------
Intrinsic Value_5Y_min---12.340--------
Market Cap17977368156.800-63%29232576709.00035645351610.850-18%38761502724.000-25%37382144865.466-22%29211465958.167+0%
Net Profit Margin--0.1460.093+57%0.192-24%0.134+9%0.110+33%
Operating Margin---0.106-100%0.235-100%0.163-100%0.116-100%
Operating Ratio--1.5991.505+6%1.289+24%1.321+21%1.103+45%
Pb Ratio2.072-63%3.3694.076-17%5.185-35%8.600-61%7.576-56%
Pe Ratio15.435-63%25.09947.410-47%13.848+81%40.714-38%50.221-50%
Price Per Share38.350-63%62.36076.040-18%82.688-25%79.745-22%62.315+0%
Price To Free Cash Flow Ratio-39.121+39%-63.614-76.529+20%-0.982-98%-54.806-14%-37.519-41%
Price To Total Gains Ratio59.233-63%96.317170.119-43%45.251+113%244.754-61%-31.244+132%
Quick Ratio--2.0491.815+13%1.441+42%1.299+58%1.190+72%
Return On Assets--0.0240.017+41%0.059-59%0.042-43%0.034-30%
Return On Equity--0.0340.026+33%0.100-66%0.075-54%0.063-46%
Total Gains Per Share--0.6470.508+27%1.843-65%0.918-29%0.815-21%
Usd Book Value--1198260347.6861206557169.798-1%1065627923.988+12%718293400.400+67%573804646.717+109%
Usd Book Value Change Per Share--0.0890.008+976%0.209-57%0.100-11%0.091-2%
Usd Book Value Per Share--2.5562.574-1%2.273+12%1.532+67%1.224+109%
Usd Dividend Per Share--0.0000.062-99%0.045-99%0.026-99%0.021-98%
Usd Eps--0.0860.065+32%0.221-61%0.111-23%0.083+3%
Usd Free Cash Flow---15865190.50711807046.235-234%50527246.636-131%26622543.326-160%16325203.654-197%
Usd Free Cash Flow Per Share---0.0340.025-234%0.108-131%0.057-160%0.038-190%
Usd Free Cash Flow To Equity Per Share---0.034-0.058+71%0.055-161%0.024-240%0.024-239%
Usd Market Cap2482674542.454-63%4037018843.5134922623057.458-18%5352963526.184-25%5162474205.921-22%4034103448.823+0%
Usd Price Per Share5.296-63%8.61210.501-18%11.419-25%11.013-22%8.606+0%
Usd Profit--40211089.43130397852.968+32%103428475.282-61%51514585.828-22%38786236.594+4%
Usd Revenue--276353347.814330672979.266-16%536307589.944-48%326205666.838-15%272454625.423+1%
Usd Total Gains Per Share--0.0890.070+27%0.255-65%0.127-29%0.112-21%
 EOD+3 -5MRQTTM+19 -16YOY+11 -245Y+13 -2310Y+20 -16

3.2. Fundamental Score

Let's check the fundamental score of Guangzhou Kingmed Diagnostics Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.435
Price to Book Ratio (EOD)Between0-12.072
Net Profit Margin (MRQ)Greater than00.146
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.049
Current Ratio (MRQ)Greater than12.919
Debt to Asset Ratio (MRQ)Less than10.287
Debt to Equity Ratio (MRQ)Less than10.411
Return on Equity (MRQ)Greater than0.150.034
Return on Assets (MRQ)Greater than0.050.024
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Guangzhou Kingmed Diagnostics Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.226
Ma 20Greater thanMa 5046.444
Ma 50Greater thanMa 10054.008
Ma 100Greater thanMa 20056.518
OpenGreater thanClose40.400
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets12,163,052
Total Liabilities3,486,294
Total Stockholder Equity8,475,914
 As reported
Total Liabilities 3,486,294
Total Stockholder Equity+ 8,475,914
Total Assets = 12,163,052

Assets

Total Assets12,163,052
Total Current Assets8,602,263
Long-term Assets3,560,790
Total Current Assets
Cash And Cash Equivalents 2,058,364
Net Receivables 6,038,077
Inventory 272,972
Other Current Assets 69,719
Total Current Assets  (as reported)8,602,263
Total Current Assets  (calculated)8,439,132
+/- 163,131
Long-term Assets
Property Plant Equipment 2,324,879
Goodwill 51,443
Intangible Assets 151,476
Long-term Assets Other 24,116
Long-term Assets  (as reported)3,560,790
Long-term Assets  (calculated)2,551,915
+/- 1,008,875

Liabilities & Shareholders' Equity

Total Current Liabilities2,946,558
Long-term Liabilities539,736
Total Stockholder Equity8,475,914
Total Current Liabilities
Short Long Term Debt 1,000
Accounts payable 2,181,920
Other Current Liabilities 500
Total Current Liabilities  (as reported)2,946,558
Total Current Liabilities  (calculated)2,183,420
+/- 763,138
Long-term Liabilities
Long term Debt 246,850
Capital Lease Obligations Min Short Term Debt200,348
Long-term Liabilities  (as reported)539,736
Long-term Liabilities  (calculated)447,198
+/- 92,538
Total Stockholder Equity
Retained Earnings 6,140,260
Total Stockholder Equity (as reported)8,475,914
Total Stockholder Equity (calculated)6,140,260
+/- 2,335,654
Other
Capital Stock468,771
Common Stock Shares Outstanding 468,771
Net Invested Capital 8,723,764
Net Working Capital 5,655,705
Property Plant and Equipment Gross 2,324,879



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-312015-09-302014-12-312013-12-312012-12-31
> Total Assets 
628,948
860,638
1,382,104
1,964,284
2,002,416
2,667,551
0
2,837,317
3,432,211
3,321,126
3,326,566
3,691,687
3,923,997
0
4,085,887
4,223,131
4,389,463
4,395,467
4,483,122
5,532,531
6,314,775
6,639,313
7,921,716
8,639,765
9,586,128
10,750,892
12,564,422
13,742,987
13,913,229
13,890,708
13,409,370
12,231,092
12,163,052
12,163,05212,231,09213,409,37013,890,70813,913,22913,742,98712,564,42210,750,8929,586,1288,639,7657,921,7166,639,3136,314,7755,532,5314,483,1224,395,4674,389,4634,223,1314,085,88703,923,9973,691,6873,326,5663,321,1263,432,2112,837,31702,667,5512,002,4161,964,2841,382,104860,638628,948
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,535,940
2,661,132
2,819,115
2,795,284
2,867,663
3,836,828
4,526,176
4,761,665
5,698,166
6,247,987
6,946,227
7,930,265
9,648,364
10,809,692
10,885,671
10,659,634
10,124,855
8,867,487
8,602,263
8,602,2638,867,48710,124,85510,659,63410,885,67110,809,6929,648,3647,930,2656,946,2276,247,9875,698,1664,761,6654,526,1763,836,8282,867,6632,795,2842,819,1152,661,1322,535,94000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
788,052
772,658
832,999
954,942
764,197
922,427
1,391,615
1,635,297
1,725,111
1,788,149
1,878,133
2,653,447
2,468,179
3,036,051
2,672,185
2,928,686
2,946,512
2,004,232
2,058,364
2,058,3642,004,2322,946,5122,928,6862,672,1853,036,0512,468,1792,653,4471,878,1331,788,1491,725,1111,635,2971,391,615922,427764,197954,942832,999772,658788,05200000000000000
       Net Receivables 
238,900
346,742
437,257
643,729
617,203
821,850
0
1,095,612
1,168,063
1,098,652
1,216,883
1,390,600
1,466,715
0
1,520,630
1,643,715
1,682,457
1,616,440
1,881,261
2,661,746
2,847,088
2,826,141
3,606,985
4,122,391
4,671,544
4,869,941
6,689,381
7,353,932
7,748,897
7,227,267
6,807,548
6,518,857
6,038,077
6,038,0776,518,8576,807,5487,227,2677,748,8977,353,9326,689,3814,869,9414,671,5444,122,3913,606,9852,826,1412,847,0882,661,7461,881,2611,616,4401,682,4571,643,7151,520,63001,466,7151,390,6001,216,8831,098,6521,168,0631,095,6120821,850617,203643,729437,257346,742238,900
       Other Current Assets 
14,098
16,457
16,016
30,104
36,424
46,777
0
30,339
31,909
59,222
39,472
38,428
39,670
0
33,684
33,074
32,754
17,679
50,604
16,854
54,785
19,093
58,449
18,061
67,569
18,736
67,742
16,382
74,218
98,426
76,086
26,751
69,719
69,71926,75176,08698,42674,21816,38267,74218,73667,56918,06158,44919,09354,78516,85450,60417,67932,75433,07433,684039,67038,42839,47259,22231,90930,339046,77736,42430,10416,01616,45714,098
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,549,947
1,561,999
1,570,349
1,600,183
1,615,459
1,695,703
1,788,599
1,877,648
2,223,550
2,391,777
2,639,901
2,820,627
2,916,058
2,933,294
3,027,558
3,231,074
3,284,514
3,363,606
3,560,790
3,560,7903,363,6063,284,5143,231,0743,027,5582,933,2942,916,0582,820,6272,639,9012,391,7772,223,5501,877,6481,788,5991,695,7031,615,4591,600,1831,570,3491,561,9991,549,94700000000000000
       Property Plant Equipment 
106,073
147,120
193,657
685,748
788,954
949,094
0
1,053,472
1,087,258
1,130,789
1,148,046
1,185,491
1,197,210
1,161,926
1,134,663
1,113,181
1,113,176
1,091,368
1,059,194
1,077,279
1,144,195
1,224,916
1,509,868
1,684,920
1,818,001
1,967,637
2,025,536
2,025,184
2,101,004
2,215,292
2,232,182
2,371,576
2,324,879
2,324,8792,371,5762,232,1822,215,2922,101,0042,025,1842,025,5361,967,6371,818,0011,684,9201,509,8681,224,9161,144,1951,077,2791,059,1941,091,3681,113,1761,113,1811,134,6631,161,9261,197,2101,185,4911,148,0461,130,7891,087,2581,053,4720949,094788,954685,748193,657147,120106,073
       Goodwill 
5,817
8,073
13,350
15,005
15,005
15,005
0
15,005
15,005
15,005
15,005
15,005
15,005
0
13,350
13,350
21,650
13,350
13,350
13,350
13,350
13,350
13,350
13,350
13,350
13,350
13,350
13,350
13,350
32,680
32,680
32,680
51,443
51,44332,68032,68032,68013,35013,35013,35013,35013,35013,35013,35013,35013,35013,35013,35013,35021,65013,35013,350015,00515,00515,00515,00515,00515,005015,00515,00515,00513,3508,0735,817
       Intangible Assets 
9,313
10,801
15,338
17,875
17,693
71,401
0
102,203
100,959
102,586
99,126
95,854
93,246
0
91,466
53,174
83,285
79,848
75,147
146,845
142,625
138,628
133,535
132,358
128,414
68,410
66,964
77,133
78,243
152,003
149,648
147,625
151,476
151,476147,625149,648152,00378,24377,13366,96468,410128,414132,358133,535138,628142,625146,84575,14779,84883,28553,17491,466093,24695,85499,126102,586100,959102,203071,40117,69317,87515,33810,8019,313
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,419
56,581
22,556
44,837
92,932
34,457
1,188,949
41,479
88,589
73,428
129,764
148,499
154,891
160,795
157,777
114,079
105,051
31,373
24,116
24,11631,373105,051114,079157,777160,795154,891148,499129,76473,42888,58941,4791,188,94934,45792,93244,83722,55656,58154,41900000000000000
> Total Liabilities 
425,262
602,226
996,835
1,016,181
1,042,574
1,533,987
0
1,628,005
1,737,927
1,577,032
1,590,556
1,897,808
2,053,989
0
2,105,301
2,156,552
2,152,579
2,069,763
2,155,254
2,731,974
2,939,867
2,762,731
3,322,134
3,611,125
3,861,661
4,228,299
5,114,640
5,414,404
5,348,787
5,015,880
4,388,203
3,856,498
3,486,294
3,486,2943,856,4984,388,2035,015,8805,348,7875,414,4045,114,6404,228,2993,861,6613,611,1253,322,1342,762,7312,939,8672,731,9742,155,2542,069,7632,152,5792,156,5522,105,30102,053,9891,897,8081,590,5561,577,0321,737,9271,628,00501,533,9871,042,5741,016,181996,835602,226425,262
   > Total Current Liabilities 
408,296
583,514
769,198
753,614
787,695
1,015,587
0
1,087,005
1,121,549
1,001,681
1,028,046
1,237,046
1,349,311
0
1,525,313
1,715,976
1,681,440
1,648,790
1,577,017
2,088,758
2,333,445
2,311,437
2,648,352
3,105,185
3,285,349
3,728,097
4,671,562
5,032,649
4,954,930
4,580,424
3,976,247
3,396,900
2,946,558
2,946,5583,396,9003,976,2474,580,4244,954,9305,032,6494,671,5623,728,0973,285,3493,105,1852,648,3522,311,4372,333,4452,088,7581,577,0171,648,7901,681,4401,715,9761,525,31301,349,3111,237,0461,028,0461,001,6811,121,5491,087,00501,015,587787,695753,614769,198583,514408,296
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,212
37,171
34,269
34,267
18,947
0
0
0
0
0
0
0
1,000
1,000000000018,94734,26734,26937,17118,21200000000000000000000
       Accounts payable 
186,157
236,672
284,552
436,601
453,691
575,299
0
747,718
795,179
752,620
811,621
956,243
989,794
0
1,006,315
1,058,594
1,112,594
1,088,387
1,108,460
1,444,057
1,719,916
1,626,533
1,882,003
2,091,238
2,245,213
2,282,755
2,921,668
3,299,866
3,354,904
2,988,243
2,749,070
2,520,036
2,181,920
2,181,9202,520,0362,749,0702,988,2433,354,9043,299,8662,921,6682,282,7552,245,2132,091,2381,882,0031,626,5331,719,9161,444,0571,108,4601,088,3871,112,5941,058,5941,006,3150989,794956,243811,621752,620795,179747,7180575,299453,691436,601284,552236,672186,157
       Other Current Liabilities 
77,338
117,042
284,646
172,013
159,904
205,738
0
194,736
226,370
208,910
176,275
240,652
359,517
0
240,834
345,940
260,342
166,505
208,106
218,901
353,413
239,013
403,002
268,656
473,074
600,031
1,113,094
868,300
748,639
645,765
499,088
338,818
500
500338,818499,088645,765748,639868,3001,113,094600,031473,074268,656403,002239,013353,413218,901208,106166,505260,342345,940240,8340359,517240,652176,275208,910226,370194,7360205,738159,904172,013284,646117,04277,338
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
579,988
440,576
471,138
420,973
578,237
643,216
606,422
451,294
673,781
505,940
576,312
500,201
443,078
381,755
393,858
435,456
411,956
459,598
539,736
539,736459,598411,956435,456393,858381,755443,078500,201576,312505,940673,781451,294606,422643,216578,237420,973471,138440,576579,98800000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
230,879
133,454
224,255
172,388
138,540
133,793
154,325
203,631
185,437
216,343
200,348
200,348216,343185,437203,631154,325133,793138,540172,388224,255133,454230,8790000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
538,166
388,512
410,008
358,700
517,082
579,207
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000579,207517,082358,700410,008388,512538,16600000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
130,198
140,997
137,147
131,530
150,571
147,631
155,226
169,051
176,872
169,729
168,186
175,202
197,686
209,129
219,811
231,916
255,195
257,004
241,434
0
0241,434257,004255,195231,916219,811209,129197,686175,202168,186169,729176,872169,051155,226147,631150,571131,530137,147140,997130,1980000000000000
> Total Stockholder Equity
181,755
233,186
368,924
924,010
930,074
1,100,382
1,133,565
1,184,169
1,661,482
1,702,268
1,711,182
1,760,637
1,829,678
0
1,950,811
2,036,321
2,188,308
2,274,779
2,306,264
2,756,131
3,310,819
3,787,213
4,493,777
4,892,246
5,583,639
6,303,809
7,188,921
8,035,180
8,336,735
8,631,455
8,786,071
8,132,423
8,475,914
8,475,9148,132,4238,786,0718,631,4558,336,7358,035,1807,188,9216,303,8095,583,6394,892,2464,493,7773,787,2133,310,8192,756,1312,306,2642,274,7792,188,3082,036,3211,950,81101,829,6781,760,6371,711,1821,702,2681,661,4821,184,1691,133,5651,100,382930,074924,010368,924233,186181,755
   Common Stock
8,078
8,078
19,749
389,205
389,205
389,205
0
389,205
457,885
457,885
457,885
457,885
457,885
457,885
457,885
457,885
457,885
457,885
457,885
457,885
459,488
459,488
462,611
462,611
463,959
465,586
465,791
465,791
467,139
467,139
467,304
467,304
0
0467,304467,304467,139467,139465,791465,791465,586463,959462,611462,611459,488459,488457,885457,885457,885457,885457,885457,885457,885457,885457,885457,885457,885457,885389,2050389,205389,205389,20519,7498,0788,078
   Retained Earnings 
17,842
70,289
127,109
19,780
60,330
221,468
0
305,557
369,026
409,973
419,400
467,945
536,294
605,290
600,306
680,230
827,551
958,170
1,006,080
1,451,791
1,950,822
2,405,599
2,943,690
3,312,634
3,925,628
4,473,041
5,323,214
6,116,010
6,325,171
6,629,613
6,779,226
6,082,656
6,140,260
6,140,2606,082,6566,779,2266,629,6136,325,1716,116,0105,323,2144,473,0413,925,6283,312,6342,943,6902,405,5991,950,8221,451,7911,006,080958,170827,551680,230600,306605,290536,294467,945419,400409,973369,026305,5570221,46860,33019,780127,10970,28917,842
   Capital Surplus 000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,042
844
1,379
1,987
1,796
2,145
2,142
1,103
-1,762
407
-3,060
-2,368
-11,763
-12,790
10,678
40,362
18,043
3,172
31,316
0
031,3163,17218,04340,36210,678-12,790-11,763-2,368-3,060407-1,7621,1032,1422,1451,7961,9871,3798441,0420000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue9,577,784
Cost of Revenue-6,012,443
Gross Profit3,565,3413,565,341
 
Operating Income (+$)
Gross Profit3,565,341
Operating Expense-8,385,577
Operating Income1,192,206-4,820,236
 
Operating Expense (+$)
Research Development540,830
Selling General Administrative1,269,790
Selling And Marketing Expenses-
Operating Expense8,385,5771,810,620
 
Net Interest Income (+$)
Interest Income33,735
Interest Expense-21,706
Other Finance Cost-8,287
Net Interest Income3,742
 
Pretax Income (+$)
Operating Income1,192,206
Net Interest Income3,742
Other Non-Operating Income Expenses-
Income Before Tax (EBT)970,7011,192,206
EBIT - interestExpense = -21,706
880,459
902,165
Interest Expense21,706
Earnings Before Interest and Taxes (EBIT)-992,407
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax970,701
Tax Provision-96,222
Net Income From Continuing Ops874,479874,479
Net Income880,459
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--3,742
 

Technical Analysis of Kingmed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kingmed. The general trend of Kingmed is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kingmed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangzhou Kingmed Diagnostics Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 50.31 < 50.50 < 56.06.

The bearish price targets are: .

Tweet this
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangzhou Kingmed Diagnostics Group Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangzhou Kingmed Diagnostics Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangzhou Kingmed Diagnostics Group Co Ltd. The current macd is -4.2869675.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kingmed price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Kingmed. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Kingmed price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuangzhou Kingmed Diagnostics Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangzhou Kingmed Diagnostics Group Co Ltd. The current adx is 52.62.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Kingmed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangzhou Kingmed Diagnostics Group Co Ltd. The current sar is 42.16.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangzhou Kingmed Diagnostics Group Co Ltd. The current rsi is 22.23. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Relative Strength Index (RSI) ChartGuangzhou Kingmed Diagnostics Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangzhou Kingmed Diagnostics Group Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kingmed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Stochastic Oscillator ChartGuangzhou Kingmed Diagnostics Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangzhou Kingmed Diagnostics Group Co Ltd. The current cci is -132.28326846.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Commodity Channel Index (CCI) ChartGuangzhou Kingmed Diagnostics Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangzhou Kingmed Diagnostics Group Co Ltd. The current cmo is -57.47171359.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuangzhou Kingmed Diagnostics Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangzhou Kingmed Diagnostics Group Co Ltd. The current willr is -95.57344064.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Williams %R ChartGuangzhou Kingmed Diagnostics Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangzhou Kingmed Diagnostics Group Co Ltd.

Guangzhou Kingmed Diagnostics Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangzhou Kingmed Diagnostics Group Co Ltd. The current atr is 2.12409749.

Guangzhou Kingmed Diagnostics Group Co Ltd Daily Average True Range (ATR) ChartGuangzhou Kingmed Diagnostics Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangzhou Kingmed Diagnostics Group Co Ltd. The current obv is -121,728,111.

Guangzhou Kingmed Diagnostics Group Co Ltd Daily On-Balance Volume (OBV) ChartGuangzhou Kingmed Diagnostics Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangzhou Kingmed Diagnostics Group Co Ltd. The current mfi is 26.53.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Guangzhou Kingmed Diagnostics Group Co Ltd Daily Money Flow Index (MFI) ChartGuangzhou Kingmed Diagnostics Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangzhou Kingmed Diagnostics Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Guangzhou Kingmed Diagnostics Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangzhou Kingmed Diagnostics Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.226
Ma 20Greater thanMa 5046.444
Ma 50Greater thanMa 10054.008
Ma 100Greater thanMa 20056.518
OpenGreater thanClose40.400
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Kingmed with someone you think should read this too:
  • Are you bullish or bearish on Kingmed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kingmed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangzhou Kingmed Diagnostics Group Co Ltd

I send you an email if I find something interesting about Guangzhou Kingmed Diagnostics Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guangzhou Kingmed Diagnostics Group Co Ltd.

Receive notifications about Guangzhou Kingmed Diagnostics Group Co Ltd in your mailbox!